Safety and Efficacy of OMS302 in Subjects Undergoing Unilateral Cataract Extraction With Lens Replacement (CELR)
Sponsored by Omeros Corporation
About this trial
Last updated 11 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Not accepting
Trial Timing
Ended 14 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Competent and willing to voluntarily provide informed consent
- 18 years of age or older
- In good general health needing to undergo cataract extraction with lens replacement surgery in one eye, under topical anesthesia
- Other inclusion criteria to be evaluated by the investigator
Exclusion Criteria
- No allergies to the medications and/or the active ingredients of any of the study medications
- No medications with the same activities as the of the active ingredients in OMS302 for defined time intervals prior to and after surgery
- No other significant eye injuries, eye conditions or general medical conditions likely to interfere with the evaluation of the study medication
- Other exclusion criteria to be evaluated by the investigator